FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Interim Compounding with Bulk Substances Policy

[ Price : $8.95]

FDA issues a guidance on an interim regulatory policy for outsourcing facilities compounding drugs from bulk drug substances.

FDA Partial Hold on Novartis/AveXis AVXS-101 Trials

[ Price : $8.95]

FDA puts a partial hold on intrathecal clinical trials of Novartis/AveXis AVXS-101.

Innovative Wants Restrictions on IB-Stim Equivalence

[ Price : $8.95]

Innovative Health Solutions asks FDA to require preclinical studies and at least one clinical trial to demonstrate substantial equ...

Biogen Gains Vumerity Approval for MS

[ Price : $8.95]

FDA approves a Biogen NDA for Vumerity (diroximel fumarate) for treating relapsing forms of multiple sclerosis.

Breakthrough Status for Enhanced Pulse Oximeter

[ Price : $8.95]

FDA grants Breakthrough Device status to Med-botics for its Oxalert EPO (Enhanced Pulse Oximeter), a wrist-worn arousal device des...

Impulse Dynamics New Optimizer Smart System OKd

[ Price : $8.95]

FDA approves an Impulse Dynamics PMA supplement for its next generation of the implantable Optimizer Smart System for delivering c...

FDA Flexible in Weighing Medical Device Uncertainty

[ Price : $8.95]

CDRHer Charles Viviano explains on a Webinar a new guidance on how the Center is flexible in weighing uncertainty in making medica...

Ethicon Echelon Flex Stapler Recall is Class 1

[ Price : $8.95]

FDA says an Ethicon recall of its Echelon Flex staplers is Class 1.

Woodcock Pushes Advanced Drug Manufacturing Technologies

[ Price : $8.95]

CDER director Janet Woodcock says advanced manufacturing technologies could reduce U.S. drug maker reliance on foreign-sourced act...

PET Drug CGMP Issues at Petnet

[ Price : $8.95]

FDA warns Petnet Solutions about CGMP violations in its manufacturing of positron emission tomography drugs.